The effective threshold dose of etanercept in patients with methotrexate-resistant rheumatoid arthritis

INTRODUCTION: The therapy of rheumatoid arthritis (RA) was advanced by biological agents, yet costly. This study aims to identify the effective threshold dose of etanercept (ENT) and cost-effectiveness in methotrexate (MTX)-resistant RA in real world. METHODS: Eligible patients had an inadequate res...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Fangfang, Lang, Yitian, Geng, Shikai, Wang, Xiaodong, Lu, Liangjing, Ye, Shuang, Zhang, Le, Li, Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497429/
https://www.ncbi.nlm.nih.gov/pubmed/37415053
http://dx.doi.org/10.1007/s10067-023-06659-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497429/
https://www.ncbi.nlm.nih.gov/pubmed/37415053
http://dx.doi.org/10.1007/s10067-023-06659-9

Ejemplares similares